Clinical Trials
11 trialsNCT05152927 2025-12-15
Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
University of California, San Francisco
Phase NA Completed
NCT05022641 2025-08-27
Evaluating Impact of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy
University of Michigan
Phase NA Completed
NCT04299425 2024-05-13
NIRAF
Vanderbilt-Ingram Cancer Center
Phase NA Completed
NCT00001277 2022-06-07
Studies of Elevated Parathyroid Activity
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03516747 2022-04-11
Preoperational Fine Needle Aspiration of Pathological Parathyroid Gland
HaEmek Medical Center, Israel
Phase NA Withdrawn
NCT01447914 2019-08-28
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00896454 2018-10-17
Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium
Amgen
Phase 2 Completed
NCT00325104 2017-07-02
Cinacalcet to Treat Familial Primary Hyperparathyroidism
National Institutes of Health Clinical Center (CC)
Phase 3 Completed
NCT01460030 2017-03-03
An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism
Kyowa Kirin Co., Ltd.
Phase 3 Completed
NCT00126386 2011-11-21
Zometa for the Management of Tumor-induced Hypercalcemia and Malignant Bone Pain in the Community
AHS Cancer Control Alberta
Phase NA Completed
NCT00051779 2005-06-24
An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer
Chugai Pharma USA
Phase 1 Completed